Budesonide–formoterol reliever therapy significantly reduces airway inflammation vs SABA in adults with mild to moderate asthma using ICS.

Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomized controlled trial to investigate the use of a ...

Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomised controlled trial to investigate the use of a ...

The cost profile of single maintenance and reliever therapy, also known as SMART or single-inhaler therapy, was “favorable” ...

The asthma guidelines were updated in September, and it is now recommended that even the mildest of asthma symptoms in people over the age of 12 be treated with a combination of inhaled steroids, ...

Inhalers that combine providing immediate relief with a longer-term preventative effect are already recommended as the standard treatment for mild asthma among people aged 12 and above in the UK, US ...

Adults with mild-to-moderate asthma who take regular inhaled corticosteroids can achieve greater control of airway inflammation by also using the 2-in-1 combination budesonide-formoterol as a reliever ...

Asthma causes inflammation and narrowing of the airways, making it harder to breathe. Symptoms may include wheezing, coughing, chest tightness, and shortness of breath. These symptoms can vary in ...